Icon
+91 94997 68112
Login Register

Chantix - (0.5 mg, 1 mg; Tablet)

Varenicline Tartrate Pfizer
0.5 mg, 1 mg; Tablet
Less Than $1000 mn
Less Than 5
Less Than 5
More Than 5
Less Than 5
More Than 5
More Than 5
Used for patients with severe renal impairment (estimated creatinine clearance less than 30 mL per min), the recommended starting dose of CHANTIX is 0.5 mg once daily.
Yes
***** & ****** **** *** ***** ** **** **** ** **** ******* ******* (*** *, ****), ******* (*** *, ****). ** ** ********* ** **** **** ***** ** *** **** ****** ********** *** **** *******(*** **, ****) ***** ** *** ********** ** *** ********. ********** *** ********* **** ***** *** ****** ****** * **** ***** **** ***** ** ****** **** ****** ** *** ********* ****** ********** ***** *** **, **** *** **** ** ********* ** ****** *** ******. ****** *** ********* ******** ****** ********** ** ** ****** ****. ********* ****** ** ******** *** *** **** ***********. ** ** ********* ** **** ***** **** *** ******** ********* ******** ****** ********** ****, ***** ****** **** ****** ** *** ****. ********* ****** **** ****** ******* ******* ***** ********** ** ***** ****** *** **** ** *** **** ** ****** **** ****** ***** *** **** ***********. *****, ****** ********* ****** **** **** ** *** ******* **'* **** **. ****** *** ****** ***** * **** ** ** ******* '*** *** '***. ****** ***** * **** ******* ****** ** ******* '*** *** '***.
Chantix Patent 1 Patent 2 Patent 3
***** ******* ******* *******
****** ******* ******* *******
*** ****** ******* ******* *******
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
***** *** \ ** ***** *, **** ******* ******** ******** ** *** **, ****
****** *** \ ** ***** *, **** ******* ******** ******** ** *** ****
*** ****** *** \ *** *** ********* ******* ******** ******** ** **** **, ****
  1. *** *, **** : ***** *** * **** ** *******. *******, **** * **** *** ***** ** ** ***** *** ***** *** ******. ***** & ****** ******** ****** ***** ***** **** ** ****** **** ******* *** ******* '*** & '***.
  2. *** **, **** : ****** ***** * **** ******* ***** & ****** ** ******** ***** ** ******** ******** ** *** ****.
  3. *** **, **** : ********** ********* **** ***** *** ******
  4. *** **, **** : ****** *** ********* ********
  5. *** **, **** : *** ****** ***** * ********* *** *********** ********* ******* ********* ** *** ************ *** ********** ** ******* '*** *** '***
  6. *** **, **** : ********** ********* ******* ****** *** *** ****** *** *********** ******** ** ***-************
  7. *** **, **** : ****** ****** ***** * ********* *** *********** ********* ******* ********* ** *** ************ *** ********** ** ******* '*** *** '***
  8. *** *, **** : ********** ********* ******* ****** *** ****** ****** *** *********** ******** ** ***-************
  9. *** **, **** : ***** ****** ******** ****** ***** ***** **** ** ****** **** ******* *** ******* '***, '*** & '***
  10. *** *, **** : ****** ***** * **** ******* ***** ****** ** ******* '***, '*** & '***.
  11. *** **, **** : ****** ********* ********** **** ***** ******. ** ****** ** ** * **********.
  12. *** **, **** : ****** ********* ****** **** **** ** *** ******* **'* **** **. ****** *** ****** ***** * **** ** ** ******* '*** *** '***.
  13. *** **, **** : ****** ***** * **** ******* ****** ** ******* '*** *** '***.
  14. *** **, **** : ****** ******* **** ****** **** *********** *****.

Download ParaIV Report

Download ParaIV Detailed Report

To get detailed report Contact Us

ParaIV Advanced Search






Please contact contact@researchdelta.com to get more details.

Headquarters

Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023

+91 94997 68112

nimish@researchdelta.com

Products & Services

Para IV GenUS Pharmalysis Consulting Valuation

Quick Links

Home About Career Media Coverage Contact
© Research Delta, All Right Reserved.